Drug Discovery World

JANUARY 21, 2024

As a vaccine immunologist Kanekiyo’s primary research interests are structure-based vaccine design, viral immunity, and host-pathogen interplay. As a vaccine immunologist Kanekiyo’s primary research interests are structure-based vaccine design, viral immunity, and host-pathogen interplay.

Vaccine 130

Vaccine Computational Chemistry Animal Testing Engineering 130

Drug Discovery World

JANUARY 22, 2024

Masaru Kanekiyo , Chief of Molecular Immunoengineering Section (MIS) of the Vaccine Research Center (VRC) at the US National Institute of Allergy and Infectious Diseases (NIAID), will present ‘Structural vaccinology for influenza’.

Immune Response 147

Immune Response Vaccine Engineering Virus 147

The Pharma Data

DECEMBER 15, 2020

COVID-19 Death Toll Hits 300,000 as Vaccine Rollout Begins. 15, 2020 — The number of Americans killed by COVID-19 topped 300,000 on Monday, the same day the country launched a massive vaccination campaign to curb the spread of COVID-19. KFF COVID-19 Vaccine Monitor. Professional. TUESDAY, Dec. The Washington Post Article.

Vaccine 52

Vaccine Clinical Trials FDA Science 52

The Pharma Data

JANUARY 6, 2021

Two-Thirds of Lupus Patients Likely to Take COVID-19 Vaccine. 6, 2021 — Two-thirds of people with lupus are willing to receive a COVID-19 vaccine, according to the results of a survey released by the Lupus Research Alliance. Hispanic respondents are most likely (34 percent) to say they are undecided about taking the vaccine.

Vaccine 52

Vaccine Research 52

Drug Discovery World

DECEMBER 6, 2022

As a result of clear US Food and Drug Administration (FDA) guidelines, the leading vaccine development programmes for Covid-19 were all remarkably similar. For example, care homes could have been selected at random to receive a Covid-19 vaccine, since not all care homes could be visited at once. Pre-specification of effect size .

Drug Development 246

Drug Development Vaccine Drugs Pharmaceuticals 246

The Pharma Data

DECEMBER 19, 2020

19, 2020 (Healthday News) — Moderna’s coronavirus vaccine was granted emergency use approval by the U.S. Food and Drug Administration on Friday, and it will now join Pfizer’s vaccine in an unprecedented national campaign to inoculate enough Americans to stem the spread of COVID-19. SATURDAY, Dec.

Vaccine 52

Vaccine FDA Government Hospitals 52

The Pharma Data

DECEMBER 18, 2020

Food and Drug Administration said Thursday night that it will move quickly to authorize the emergency use of Moderna’s coronavirus vaccine after one of its advisory panels voted to give its blessing to the shot. “Following today’s positive advisory committee meeting outcome regarding the Moderna COVID-19 vaccine, the U.S.

Vaccine 52

Vaccine FDA Government Hospitals 52

The Pharma Data

OCTOBER 21, 2020

Fauci ‘Cautiously Optimistic’ for COVID-19 Vaccine by Year’s End. the leading infectious disease expert in the United States, said on Wednesday he is “cautiously optimistic” that a COVID-19 vaccine will be ready by year’s end. Multiple studies are testing three vaccine approaches, Fauci said.

Vaccine 52

Vaccine Disease Trials 52

The Pharma Data

DECEMBER 16, 2020

16, 2020 (Healthday News) – The Trump administration is working to free up raw materials that Pfizer requires to make tens of millions more doses of its coronavirus vaccine in the first half of 2021. Vaccine campaign begins as poll shows 70% will get it. WEDNESDAY, Dec. On Tuesday morning, scientists from the U.S.

Vaccine 52

Vaccine Nurses Clinical Trials Hospitals 52

The Pharma Data

DECEMBER 15, 2020

15, 2020 (Healthday News) — The number of Americans killed by the new coronavirus topped 300,000 on Monday, the same day the country launched a massive vaccination campaign to curb the spread of COVID-19. TUESDAY, Dec. And on Tuesday morning, scientists from the U.S. Kaiser polled 1,676 adults for the survey.

Vaccine 52

Vaccine Nurses Clinical Trials Hospitals 52

The Pharma Data

AUGUST 24, 2020

The top US virus expert has warned against rushing out a Covid-19 vaccine before it has been proven to be safe and effective. Speaking to Reuters news agency, Dr Anthony Fauci also said doing so could hurt the development of other vaccines. Oxford coronavirus vaccine triggers immune response.

Vaccine 52

Vaccine Virus Immune Response Pharmaceutical Companies 52

The Pharma Data

JANUARY 29, 2021

Adults Want the COVID-19 Vaccine as Soon as Possible. adults are increasingly eager to get the COVID-19 vaccine, according to survey results released by the Kaiser Family Foundation (KFF) COVID-19 Vaccine Monitor. “It provides hope that vaccine confidence will build over time.” Professional. FRIDAY, Jan.

Vaccine 52

Vaccine 52

Drug Discovery World

AUGUST 1, 2023

As per a definition provided by AstraZeneca: “Once inside, ASOs bind with high specificity to target mRNA or pre-mRNA, inducing its degradation – effectively silencing it – to prevent its translation into a detrimental protein product.

RNA 130

RNA Vaccine Drugs Disease 130

Drug Discovery World

SEPTEMBER 2, 2022

The study, which launched in January 2021, included those who were vaccinated and those who were not, as well as people who were pregnant. Certainly, it’s not definitive and needs to be studied it further, but the data are suggestive that there may be something there.” . Reduction in hospitalisations. Impact on long Covid .

Drugs 243

Drugs Clinical Trials Trials Vaccine 243

The Pharma Data

APRIL 1, 2021

vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose. Vaccine was 100% effective in preventing severe disease as defined by the U.S. Vaccine was 100% effective in preventing COVID-19 cases in South Africa, where the B.1.351 Food and Drug Administration.

Vaccine 52

Vaccine FDA Licensing Licensing 52

The Pharma Data

DECEMBER 23, 2020

and the Trump Administration were close to a deal on Tuesday that would get more of the company’s coronavirus vaccine to Americans in the coming year. So far, only two pharmaceutical companies — Pfizer and Moderna — have won emergency approval for their COVID-19 vaccines. WEDNESDAY, Dec.

Vaccine 52

Vaccine Government Virus Medical Schools 52

Drug Discovery World

AUGUST 24, 2022

Although vaccines developed for smallpox may reduce the risk of catching monkeypox, there are currently no proven therapeutics to speed recovery in those who develop the disease. . Monkeypox is a member of the smallpox family of viruses and had been rare outside of west and central Africa until this year.

Research 246

Research Clinical Trials Virus Trials 246

The Pharma Data

SEPTEMBER 23, 2020

The halting of AstraZeneca’s COVID-19 vaccine trial around the world was cause for much initial concern over the eventual safety and efficacy of the therapy. Eventually, it’s the public who will either take this vaccine or not, so it is to their advantage to be transparent as possible.”. Matt Fellows. Source link.

Vaccine 52

Vaccine Trials Science Regulations 52

The Pharma Data

JUNE 24, 2021

This follows the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) positive opinion to authorize the vaccine in this age group. COMIRNATY was the first COVID-19 vaccine to receive authorization in the EU and is the first to have its CMA extended to adolescents. g doses of the COVID-19 vaccine.

Vaccine 52

Vaccine Clinical Trials FDA Trials 52

The Pharma Data

NOVEMBER 22, 2020

As the Pfizer and BioNTech COVID-19 vaccine goes to regulators and the Moderna vaccine approaches the end of its Phase III trials, AstraZeneca and the University of Oxford announced high-level results from an interim analysis of their COVID-19 vaccine, AZD1222. The combined analysis showed average efficacy of 70%.

Vaccine 52

Vaccine Virus Trials Regulations 52

The Pharma Data

DECEMBER 21, 2020

experts announced Sunday which Americans will be next in line receive a COVID-19 vaccine, health officials worldwide worried about a new strain of coronavirus that appears to spread faster than before. The two latest groups in line for a vaccine number roughly 50 million. The new COVID-19 vaccines target that spiky protein.

Vaccine 52

Vaccine Government Hospitals FDA 52

The Pharma Data

JANUARY 11, 2021

health officials raced to ramp up the delivery of COVID-19 vaccines across the country as both coronavirus case counts and death tallies continued to hit record highs. “We really need to get this vaccine out more quickly, because this is really our only tool,” Dr. Scott Gottlieb, former commissioner of the U.S. .

Vaccine 52

Vaccine Virus Assisted Living Nurses 52

Drug Discovery World

MAY 23, 2024

SD: This is definitely a challenge. It combines a vaccine component against HPV, an immunomodulator to make the tumour environment more receptive to immune attacks, and a T-cell co-stimulator to establish long-term immune memory against the tumour. CIN is a common precursor to cervical cancer.

RNA 147

RNA Therapies Engineering Disease 147

The Pharma Data

JANUARY 15, 2021

15, 2021 (American Heart Association News) — Experts have a simple answer for heart and stroke patients questioning whether they need a COVID-19 vaccination. The Food and Drug Administration-approved vaccines pose no special problems for such patients, said Elkind, who also is president of the American Heart Association.

Vaccine 52

Vaccine Virus Immune Response Disease 52

The Pharma Data

JULY 28, 2021

Safety profiles of Vaxzevria, and the mRNA-based vaccine were similar and overall favourable. Very rare clotting disorders (TTS) were observed with both vaccines but these were in line with what would be expected in the general population and lower than in those diagnosed with COVID-19.

Vaccine 52

Vaccine Virus Science Production 52

The Pharma Data

AUGUST 3, 2021

Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas Fast tracks establishment of Sanofi’s recently announced mRNA Center of Excellence Full integration upgrades drug formulation capabilities and enhances US talent in a promising new technology.

Vaccine 52

Vaccine Clinical Trials Licensing Licensing 52

FDA Law Blog: Biosimilars

JUNE 2, 2023

Most are new or revised definitions and administrative changes, but several proposals represent new policies that should be of concern to drug manufacturers. What is noteworthy about this proposed definition is that it adds a new requirement that “[a] manufacturer must make data available to CMS to support its finding.”

Drugs 59

Drugs Regulations Government Vaccine 59

Eye on FDA

AUGUST 13, 2021

What does “fully vaccinated” mean today? In the face of the widening spread of the SARS-Cov-2 variant, the rise in breakthrough cases, and data that suggests a slight waning effect over time of vaccines, FDA acted yesterday to protect some of the most vulnerable by amending the Emergency Use Authorization of the mRNA vaccines.

FDA 98

FDA Vaccine 98

The Pharma Data

DECEMBER 10, 2020

–( BUSINESS WIRE )– ImmunityBio , a privately-held immunotherapy company, today announced its COVID-19 vaccine candidate protected nasal and lung airways of non-human primates against coronavirus (SARS-CoV-2) in a challenge study. 11, 2020 02:48 UTC. CULVER CITY, Calif.–(

Vaccine 52

Vaccine Immune Response Virus Clinical Trials 52

The Pharma Data

SEPTEMBER 9, 2020

The vaccine supply for the EU would be produced by BioNTech’s manufacturing sites in Germany and Pfizer’s manufacturing site in Belgium. The proposed supply agreement with the European Commission would represent the largest initial order of vaccine doses for Pfizer and BioNTech to date. billion doses by the end of 2021.

Vaccine 52

Vaccine Clinical Trials Trials Government 52

Plenge Gen

MAY 28, 2021

In this blog I define programmable therapeutics and provide a few recent examples (severe combined immune deficiency and mRNA vaccines). As you will see, programmable therapeutics is more than pure imagination – we are seeing this new concept evolve before our very eyes. What is the concept of programmable therapeutics?

Vaccine 52

Vaccine Drug Development Trials Drugs 52

Drug Discovery World

MAY 28, 2023

In terms of pre-data generation, there is a lack of a consistent, aligned definition about what “women’s health” actually is, which leads to an uncertain foundation from which data generation can springboard. 1 Clinical trials Until recently, medicines and vaccines were mainly tested on men.

International 130

International Vaccine Nurses Clinical Trials 130

The Pharma Data

JANUARY 29, 2021

January 29, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating that the investigational single-dose COVID-19 vaccine in development at its Janssen Pharmaceutical Companies met all primary and key secondary endpoints.

Vaccine 40

Vaccine Trials Pharmaceutical Companies Immune Response 40

The Pharma Data

MAY 31, 2022

billion in potential development milestones Proposed acquisition provides access to next-generation 24-valent pneumococcal vaccine candidate in phase II development and highly innovative, MAPS TM technology Supports development of a strong portfolio of innovative vaccines and specialty medicines. GSK to pay $2.1

Vaccine 52

Vaccine Immune Response Clinical Trials Disease 52

The Pharma Data

JUNE 2, 2022

GSK plc (LSE/NYSE: GSK) announced that it has entered into a definitive agreement to acquire Affinivax, Inc. Affinivax is pioneering the development of a novel class of vaccines, the most advanced of which are next-generation pneumococcal vaccines. billion upfront payment and up to $1.2

Vaccine 52

Vaccine Immune Response Clinical Trials Disease 52

Drug Channels

FEBRUARY 22, 2022

Pharmacies and Pharmacy Benefit Managers is a definitive, nonpartisan resource that includes the most current information about pharmacy dispensing channels, third-party payers, pharmacy benefit managers (PBMs), patients’ financial contributions, government regulations, and much more. The 2022 Economic Report on U.S.

Pharmacy 96

Pharmacy Specialty Pharmacies Biosimilars Licensing 96

Drug Discovery World

FEBRUARY 27, 2023

For RNA, we’ve seen its success with Covid-19 vaccines and the approval of the first-ever RNA-targeting small molecule, risdiplam, for treating spinal muscular atrophy (SMA). RT : Definitely yes. The recent wins with the Covid-19 vaccines and the risdiplam approval demonstrate the potential of RNA.

RNA 130

RNA Science Small Molecule Engineering 130